Electrically conductive/insulative over-shoe for tissue fusion

Information

  • Patent Grant
  • 9980770
  • Patent Number
    9,980,770
  • Date Filed
    Wednesday, July 22, 2015
    9 years ago
  • Date Issued
    Tuesday, May 29, 2018
    6 years ago
Abstract
An over shoe for use with electrosurgical instruments having a pair of juxtaposed jaw members pivotably associated with one another, at least one of which includes an electrically conductive surface disposed thereon which is in electrical engagement with an electrosurgical energy source. According to one aspect of the present disclosure, the over shoe includes a tissue contacting wall configured and dimensioned to selectively and substantially overlie the electrically conductive surface of the electrosurgical instrument. The tissue contacting wall is fabricated from a non-conductive material and includes a plurality of apertures formed therethrough. In another embodiment, the tissue contacting wall is electrically conductive and is configured for selective engagement atop on of the jaw members.
Description
BACKGROUND

1. Technical Field


The present disclosure relates to electrosurgical instruments and, more particularly, an over-shoe for use in cooperation with electrosurgical instruments for controlling the amount of electrosurgical energy delivered to the tissue.


2. Description of Related Art


A hemostat and/or forceps is a simple plier-like tool which uses mechanical action between its jaws to constrict vessels and is commonly used in open surgical procedures to grasp, dissect and/or clamp tissue. Electrosurgical hemostats and/or forceps utilize both mechanical clamping action and electrical energy to effect hemostasis by heating the tissue and blood vessels, between its jaws, to cut, blend and/or coagulate tissue. An electrode operatively associated with each opposing jaw member is charged to a different electric potential such that when the jaw members grasp tissue therebetween, electrical energy can be selectively transferred through the tissue. A surgeon can cut, blend, coagulate/desiccate and/or simply reduce or slow bleeding, by controlling the intensity, frequency and duration of the electrosurgical energy applied between the electrodes and through the tissue.


“Tissue heating” is generally proportional to the square of the amount of current being generated through tissue while “tissue vaporization” is generally proportional to current and is generally proportional to the amount of energy in an arc. The amount of energy in the arc, in combination with the “Cathode Fall Voltage”, derives the “power for vaporization”. “Thermal spread” is dependent on the amount of heat generated within the tissue and is dependent on tissue resistivity and the arc energy squared. As can be appreciated, the control of “thermal spread” is an important factor in determining and controlling the depth of tissue treatment.


Accordingly, during electrosurgery, an increase or decrease in the amount of current provides and/or creates a different effect on the tissue. This phenomenon is due to a variable referred to as the crest factor (CF). The crest factor can be calculated using the formula: CF=VPEAK/VRMS, where VPEAK is the positive peak of the waveform and VRMS is the “Root Mean Square” or RMS value of the waveform. The crest factor can also be calculated using the formula: CF=[(1−D)/D]1/2, where D is the duty cycle of the waveform and is defined as D=T1/(T1+T2).


An increase in the crest factor results in more current per arc at a given power setting. Further, since “tissue heating” is proportional to the current through the tissue squared, and “tissue vaporization” is proportional to the amount of current being generated through the tissue, a doubling of current per arc results in four times as much tissue heating and twice the amount of tissue vaporization when an electrode of an electrosurgical hemostat and/or forceps, connected to the electrosurgical generator system, contacts the tissue.


Based on the above formulas, it is evident that when operating an electrosurgical generator system in either the “cut”, “blend”, “coagulate” or seal mode, the range of the crest factor varies from one mode to another. For the purposes herein, “coagulation” is defined as a process of desiccating tissue wherein the tissue cells are ruptured and dried. “Vessel sealing” is defined as the process of liquefying the collagen in the tissue so that it reforms into a fused mass with significantly-reduced demarcation between the opposing tissue structures (opposing walls of the lumen). Coagulation of small vessels is usually sufficient to permanently close them. Larger vessels need to be sealed to assure permanent closure.


Commonly assigned U.S. Application Serial Nos. PCT Application Serial No. PCT/US01/11340; U.S. application Ser. No. 10/116,824; and PCT Application Serial No. PCT/US01/11420 (all of which are hereby incorporated by reference herein) teach that to effectively seal tissue or vessels, especially large vessels, two predominant mechanical parameters must be accurately controlled: 1) the pressure applied to the vessel; and 2) the gap distance between the conductive tissue contacting surfaces (electrodes). As can be appreciated, both of these parameters are affected by the thickness of the vessel or tissue being sealed. Accurate application of pressure is important for several reasons: 1) to oppose the walls of the vessel; 2) to reduce the tissue impedance to a low enough value that allows enough electrosurgical energy through the tissue; 3) to overcome the forces of expansion during tissue heating; and 4) to contribute to the end tissue thickness which is an indication of a good seal. It has been determined that a typical sealed vessel wall is optimum between about 0.001 inches and about 0.006 inches.


With respect to electrosurgically treating relatively smaller vessels, for effective sealing, the pressure applied to the vessel becomes less relevant and the gap distance between the electrically conductive surfaces of the electrodes becomes more significant. In other words, the chances of the two electrodes touching one another during activation increases as the tissue thickness and the vessels become smaller.


As can be appreciated, when cutting, blending or coagulating vessels, the tissue disposed between the two opposing jaw members is essentially destroyed. Other known electrosurgical instruments include blade members or shearing members which simply cut tissue in a mechanical and/or electromechanical manner and, as such, also destroy tissue viability. With respect to electrosurgically treating relatively larger vessels and/or soft tissues (e.g., lung, intestine, lymph ducts, etc.), to promote healing, the above-identified surgical treatments are generally impractical due to the fact that in each instance the tissue or a significant portion thereof is essentially destroyed to create the desired surgical effect (e.g., cutting, blending and/or cauterizing) which does not promote healing.


Accordingly, the need exists for electrosurgical accessories and/or devices (e.g., an electrically conductive or insulative over-shoe) which can be used in cooperation with existing electrosurgical instruments (e.g., electrosurgical forceps) for controlling and/or limiting the current (or current per arc on a micro level) and for controlling the degree of tissue heating and the degree of tissue vaporization.


In addition, the need exists for electrosurgical accessories and/or devices (e.g., an electrically conductive or insulative over-shoe) for cooperative use with existing electrosurgical instruments (e.g., electrosurgical forceps) which allow for the effective treatment of tissue and the effective maintenance of tissue viability across the treatment area to promote tissue healing.


SUMMARY

The present disclosure relates to an over shoe for use with electrosurgical instruments having a pair of juxtaposed jaw members pivotably associated with one another. At least one of the jaw members includes an electrically conductive surface disposed thereon and in electrical engagement with an electrosurgical energy source is disclosed. According to one aspect of the present disclosure, the over shoe includes a tissue contacting wall configured and dimensioned to selectively and substantially overlie (or be selectively positioned atop) the electrically conductive surface of the electrosurgical instrument. The tissue contacting wall is preferably fabricated from a non-conductive material and includes a plurality of apertures formed therethrough.


In one embodiment the over shoe includes a tissue contacting wall fabricated from a ceramic material. The tissue contacting wall desirably includes a plurality of apertures arranged in pairs along a length of the electrically conductive surface. It is envisioned that the apertures are randomly arranged.


It is contemplated that the apertures are evenly sized. It is further envisioned that the apertures are generally circular. In one embodiment, the apertures can have diameters of about 0.000394 inches (10 μm) to about 0.0394 inches (1000 μm). In another embodiment, the apertures may be much larger and being the range of about 0.001 inches (0.0254 millimeters) to about 0.15 inches (3.81 millimeters).


It is further contemplated that the apertures are elongated slots. The elongated slots can be in at least one of a parallel orientation with respect to the longitudinal axis and at an angle with respect to the longitudinal axis.


It is envisioned that the over shoe can further include a pair of side walls extending from lateral side edges of the tissue contacting wall, and a bottom wall interconnecting the pair of side walls, the tissue contacting wall, the bottom wall and the side walls defining a cavity configured and dimensioned to substantially receive a jaw member of the electrosurgical instrument. The bottom wall can include a longitudinally oriented slot running along a length thereof which promotes friction fit engagement between the over shoe and the jaw member.


The over shoe can include at least one band extending between and engaged with each side terminal edge of the tissue contacting wall. The over shoe can include at least one inter-engaging member extending from an inner surface of at least one of the pair of side walls, the at least one inter-engaging member being configured and dimensioned to engage a complementary recess formed in the jaw member. The at least one inter-engaging member registers the apertures of an over shoe placed on one of the pair of jaw members relative to the apertures of an over shoe placed on the other of the other of the pair of jaw members. It is contemplated that the apertures can be in vertical registration and/or offset.


The tissue contacting wall can have a thickness which is in the range of about 0.000394 inches (10 μm) to about 0.0394 inches (1000 μm). The thickness of the tissue contacting wall is non-uniform.


According to another aspect of the present disclosure, the over shoe can include a tissue contacting wall fabricated from a non-conductive material, the tissue contacting wall being configured and dimensioned to over lie an electrically conductive surface disposed on the electrosurgical instrument, the tissue contacting wall including at least one aperture extending therethrough. The tissue contacting wall is desirably fabricated from a ceramic material.


It is envisioned that the tissue contacting wall is fabricated from materials having a high Comparative Tracking Index, preferably the range of about 300 to about 600 volts.


It is further envisioned that the tissue contacting wall is fabricated from a group consisting of at least one of nylons, syndiotactic polystryrenes, polybutylene terephthalate, polycarbonate, acrylonitrile butadiene styrene, polyphthalamide, polymide, polyethylene terephthalate, polyamide-imide, acrylic, polystyrene, polyether sulfone, aliphatic polyketone, acetal copolymer, polyurethane, nylon with polyphenylene-oxide dispersion, and acrylonitrile styrene acrylate.


The present disclosure also relates to an over shoe for use with electrosurgical instruments which is capable of performing tissue sealing between two opposing jaw members, the over shoe including a tissue contacting wall fabricated from a conductive material which is disposed in electrical communication with a source of electrosurgical energy. The tissue contacting wall also includes at least one sidewall which depends therefrom which defines a slot for selectively receiving at least one jaw member. The tissue contacting wall also includes at least one aperture which extends therethrough. Preferably, the jaw member is made from an insulative material.


A second over shoe may be included which is designed to substantially overlie or sit atop the second jaw member such that the jaw members are capable of conducting bipolar energy therethrough.


The present disclosure also relates to an over shoe for use with electrosurgical instruments capable of performing tissue sealing between two opposing jaw members which includes a tissue contacting wall fabricated from a non-conductive material. The tissue contacting wall includes at least one sidewall which depends therefrom which defines a slot for selectively receiving at least one jaw member. The tissue contacting wall also includes at least one protrusion extending therefrom, the protrusion being disposed in electrical communication with a source of electrosurgical energy. For bipolar electrosurgical instruments, each jaw member may include an electrically conductive overshoe.


Further features of the above embodiments will become more readily apparent to those skilled in the art from the following detailed description of the apparatus taken in conjunction with the drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments will be described herein below with reference to the drawings, wherein:



FIG. 1A is a perspective view of a prior art endoscopic forceps;



FIG. 1B is an enlarged perspective view of a jaw assembly of the prior art endoscopic forceps of FIG. 1A;



FIG. 2A is a perspective view of a prior art open forceps;



FIG. 2B is an enlarged perspective view of a jaw assembly of the prior art open forceps of FIG. 2A;



FIG. 3 is a front perspective view of an over shoe in accordance with an embodiment of the present disclosure;



FIG. 4 is a rear perspective view of the over shoe of FIG. 3;



FIG. 5 is a rear perspective view of an over shoe in accordance with yet another embodiment of the present disclosure;



FIG. 6 is a top plan view of the over shoe of FIG. 5;



FIG. 7 is a bottom plan view of the over shoe of FIGS. 5 and 6;



FIG. 8 is a rear elevational view of the over shoe of FIGS. 5-7;



FIG. 9 is a front elevational view of the over shoe of FIGS. 5-8;



FIG. 10 is a bottom perspective view of an over shoe in accordance with still another embodiment of the present disclosure;



FIG. 11 is a top plan view of a jaw member of a forceps including an over shoe, with the tissue contacting wall thereof removed therefrom, mounted thereon and illustrating an exemplary positioning arrangement for engagement of the over shoe to the jaw member;



FIG. 12 is a top plan view of an over shoe illustrating an exemplary aperture pattern formed therein;



FIG. 13 is a top plan view of an over shoe illustrating another exemplary aperture pattern formed therein;



FIG. 14 is a top plan view of an over shoe illustrating still another exemplary aperture pattern formed therein;



FIG. 15 is a top plan view of an over shoe illustrating yet another exemplary hole pattern formed therein;



FIG. 16 is an enlarged perspective view of the jaw assembly of the endoscopic forceps of FIG. 1A, illustrating the placement of an over shoe, in accordance with the present disclosure, thereon;



FIG. 17 is an enlarged perspective view of the jaw assembly of the endoscopic forceps of FIG. 2A, illustrating the placement of an over shoe, in accordance with the present disclosure, thereon;



FIG. 18A is a schematic, perspective view of exemplary jaw members approximating tissue including an over shoe, in accordance with the present disclosure, placed on at least one of the jaw members;



FIG. 18B is a schematic, perspective view of exemplary jaw members grasping tissue including an over shoe, in accordance with the present disclosure, placed on at least one of the jaw members;



FIG. 18C is an enlarged schematic side elevational view showing the individual micro-seal sites and the viable tissue areas between the two jaw members after activation of the electrode assembly;



FIG. 18D is a schematic, perspective view showing a series of micro-seals disposed in a pattern across the tissue after activation of the electrode assembly;



FIG. 19A is a schematic, perspective view of an alternate embodiment of the present disclosure showing a conductive over shoe; and



FIG. 19B is a schematic, perspective view of another alternate embodiment of the present disclosure showing a conductive over shoe with raised conductive projections.





DETAILED DESCRIPTION

Preferred embodiments of the presently disclosed instruments, devices and accessories will now be described in detail with reference to the drawing figures wherein like reference numerals identify similar or identical elements. In the drawings and in the description which follows, the term “proximal”, as is traditional, will refer to the end of the instrument, device and/or accessory which is closest to the operator while the term “distal” will refer to the end of the instrument, device and/or accessory which is furthest from the operator.


Referring to FIGS. 1A and 1B, a prior art bipolar forceps, for use in various endoscopic surgical procedures, is shown generally as 100. Forceps 100 generally includes a housing 120, a handle assembly 130, a rotating assembly 180, an activation assembly 170 and an electrode assembly 110 which mutually cooperate to grasp and seal tissue.


More particularly, forceps 100 includes a shaft 112 which has a distal end 114 dimensioned to mechanically engage a jaw assembly 110 and a proximal end 116 which mechanically engages housing 120. Shaft 112 may be bifurcated at the distal end 114 thereof to receive jaw assembly 110. Proximal end 116 of shaft 112 mechanically engages rotating assembly 180 to facilitate rotation of jaw assembly 110.


Forceps 100 also includes an electrical interface or plug 300 which connects forceps 100 to a source of electrosurgical energy, e.g., an electrosurgical generator (not shown). An electrical cable 310 extends from plug 300 and is securely connected to housing 120 of forceps 100. Cable 310 is internally divided within housing 120 to transmit electrosurgical energy through various electrical feed paths to jaw assembly 110. Handle assembly 130 includes a fixed handle 150 and a movable handle 140. Fixed handle 150 is integrally associated with housing 120 and handle 140 is movable relative to fixed handle 150 to actuate a pair of opposing jaw members 280 and 282 of jaw assembly 110.


Referring now to FIGS. 2A and 2B, a prior art open forceps is generally shown as 200. Open forceps 200 is generally in the form of a pair of scissors and includes a pair of elongated shaft portions 212a, 212b each having a proximal end 216a, 216b, respectively, and a distal end 214a, 214b, respectively. Open forceps 200 includes a jaw assembly 210 which attaches to distal end 214a, 214b of shaft portions 212a, 212b, respectively. Jaw assembly 210 includes opposing jaw members 280, 282 which are pivotably connected about a pivot pin 219.


One of shafts 212a, 212b, is operatively connected to a source of electrosurgical energy, such as an electrosurgical generator (not shown), via an electrosurgical cable 310. A proximal end of cable 310 includes a similar plug 300 as described above.


As best seen in FIGS. 1B and 2B, various electrical connections of electrode assemblies 110, 210 (not shown) are configured to provide electrical continuity to an array of electrode micro-sealing pads 500 disposed along one or both jaw members 280, 282. Commonly-assigned U.S. patent application Ser. No. 10/369,894 shows one example of an open forceps having a plurality of micro sealing pads 500 disposed on opposing electrically conductive surfaces for maintaining the viability of tissue after sealing. The contents of U.S. patent Ser. No. 10/369,894 are hereby incorporated by reference herein.


As disclosed, electrode micro-sealing pads 500 are arranged in a longitudinal, pair-like fashion along the tissue contacting surfaces of jaw members 280, 282. In use, the arrangement of micro-sealing pads 500, across the tissue, only seals the tissue which is between each micro-sealing pad 500 and the opposing jaw members 280, 282. The tissue adjacent each micro-sealing pad 500 remains viable which, as can be appreciated, allows blood and nutrients to flow through the sealed tissue and between the individual tissue welds to promote tissue healing and reduce the possibility of tissue necrosis.


Turning now to FIGS. 3 and 4, an over shoe for operative engagement with at least one of the pair of opposing jaw members 280, 282 of jaw assembly 110 of forceps 100 is shown generally as 10. For the purposes herein, over shoe 10 can be used with either an endoscopic forceps (as depicted in FIGS. 1A and 1B) or an open forceps (as depicted in FIGS. 2A and 2B). Obviously, different geometric considerations apply to use over shoe 10 with each particular type of instrument, however, the novel aspects with respect to over shoe 10 and its operating characteristics remain generally consistent with respect to both open and/or endoscopic forceps.


Over shoe 10 includes a tissue contacting wall 12 and a pair of side walls 14, 16 terminating in an arcuate bottom wall 18. Walls 12-18 of over shoe 10 define a cavity 20 therein sized and dimensioned to receive one of the pair of opposing jaw members 280, 282 therein. Over shoe 10 includes an opening 22 at a proximal end thereof for insertion of one of the pair of opposing jaw members 280, 282 therethrough (i.e., such that over shoe 10 can be “slipped” on over at least one of the pair of opposing jaw members 280, 282).


Over shoe 10 preferably includes a plurality of apertures 24 formed in tissue contacting wall 12 thereof. Preferably, apertures 24, as seen in FIGS. 3 and 4, are arranged in two linear rows, however, any arrangement and/or configuration of apertures 24 is envisioned and contemplated (see FIGS. 12-15), e.g., longitudinally offset rows.


In one embodiment, at least the upper, tissue engaging surface 12 of over shoe 10 is fabricated from a non-conductive material which acts to electrically (and/or thermally) insulate the majority of the tissue engaging wall 12 during activation allowing only a portion of electrosurgical energy through apertures 24. Alternatively and as described in more detail herein, it is also envisioned that the tissue engaging surface 12 may be electrically conductive (and/or thermally conductive or thermally non-conductive) and the apertures 24 non-conductive (and/or the end effector under the over shoe 10 is non-conductive).


Moreover, it is also contemplate that the apertures may vary greatly in size depending upon a particular purpose. For example and as mentioned above, the apertures 24 may be configured in many geometric configurations atop tissue contacting surface 12 which, depending upon the positioning of the apertures and whether the surface 12 is electrically conductive, electrically insulative and/or thermally insulative, will vary the desired tissue effect, e.g., cut, coagulate, blend, seal. In addition to the various geometric parameters which can greatly effect the tissue effect, it is envisioned that the size of the apertures 24 can also play an important role in determining tissue effect. For example, the apertures 24 may be relatively large (from arrange of about 0.001 inches in diameter to about 0.15 inches in diameter (or larger)) for sealing large tissues to maintain viability across the tissue seal as described in commonly owned, U.S. application Ser. No. 10/369,894 the entire contents of which are hereby incorporated by reference herein.


The apertures 24 may also be very small apertures 24 (a diameter in the range of about 0.000394 inches (10 μm) to about 0.0394 inches (1000 μm)) for limiting the current per arc through the tissue surface 12 for creating certain surgical effects as described in commonly-owned, Provisional Patent Application Serial No. 60/432,385 (now U.S. Pat. No. 7,033,354 to David S. Keppel, the entire contents of which are hereby incorporated by reference herein. When the tissue engaging surface 12 is fabricated from non-conductive material, the non-conductive material essentially “pinches” or splits the arc current generated by the electrosurgical generator into a small diameter channel, effectively keeping the same current and voltage, but creating several small arcs from one large arc. Essentially, this has the effect of separating the arc current, effectively increasing the current effect to the tissue, resulting in a finer cut and/or other surgical effect. In other words, the non-conductive material enables a low frequency current to achieve surgical effects and/or results indicative of a high frequency current, while minimizing or preventing thermal damage to adjacent tissue.


As mentioned above, apertures 24 may have a uniform diameter in the range of about 0.000394 inches (10 μm) to about 0.0394 inches (1000 μm). The number of small arcs created from one large arc is inversely proportional to the diameter of apertures 24 formed in tissue contacting wall 12. Preferably, the diameter of each aperture 24 is less than the diameter of the large arc. Hence, when electrosurgical current is applied, for example, to electrode assembly 110 of forceps 100, when over shoe 10 is placed thereon, the arc current is split between apertures 24, thereby controlling or limiting the arc current through each aperture 24. This effect which controls or limits the arc current through each aperture 24 is referred to as “MicroHollow Cathode Discharge” (MCD or MHCD). Commonly owned International Patent Application Serial No. PCT/US03/08146, discloses a porous coating which may be utilized to control arc current, the entire contents being hereby incorporated by reference herein. A large arc area is desired when operating the electrosurgical generator in the coagulation mode while a small arc area is desired when operating the electrosurgical generator in the cut mode.


Moreover, it is envisioned that a series of different over shoes 10 may be sold as a pack to change the desired surgical effect based on size of apertures, geometrical configuration or layout of the apertures for cut, coagulation, sealing, blend, etc.)


In one embodiment, over shoe 10 is made from an insulative material such as ceramic due to its hardness and inherent ability to withstand high temperature fluctuations. Alternatively, over shoe 10 may be made from a material or a combination of materials having a high Comparative Tracking Index (CTI) in the range of about 300 to about 600 volts. Examples of high CTI materials include nylons and syndiotactic polystryrenes such as QUESTRA® manufactured by DOW Chemical. Other materials may also be utilized either alone or in combination, e.g., Nylons, Syndiotactic-polystryrene (SPS), Polybutylene Terephthalate (PBT), Polycarbonate (PC), Acrylonitrile Butadiene Styrene (ABS), Polyphthalamide (PPA), Polymide, Polyethylene Terephthalate (PET), Polyamide-imide (PAI), Acrylic (PMMA), Polystyrene (PS and HIPS), Polyether Sulfone (PES), Aliphatic Polyketone, Acetal (POM) Copolymer, Polyurethane (PU and TPU), Nylon with Polyphenylene-oxide dispersion and Acrylonitrile Styrene Acrylate.


The diameter of each of the plurality of apertures 24 can vary in size to produce different surgical effects when operating the electrosurgical generator system in one of several modes, such as, for example, in seal, cut, blend and coagulation modes. In any of these embodiments, the size of the aperture enables the surgeon to control the proportion of tissue vaporization to tissue heating, in order to achieve more controllable and desirable surgical effects. For example, relatively larger apertures 24 (e.g., on the order of about 0.001 inches to about 0.15 inches in diameter (or larger)) are desirable for effecting sealing of relatively large tissue in order to create a micro-sealing pattern across the tissue (see FIG. 18D). Moreover, relatively smaller apertures 24 are desirable for effecting cutting, blending and/or coagulating of relatively smaller tissue. It is envisioned and within the scope of the present disclosure that tissue contacting wall 12 of over shoe 10 can include regions wherein at least one of the regions includes apertures 24 sized to provide one tissue effect, e.g., sealing, and at least one other region includes apertures 24 sized to provide a different surgical effect, e.g., cutting, blending and/or coagulating.


The number of apertures 24 per square centimeter can be uniform or vary along the length of over shoe 10 and/or electrode assembly 110 of forceps 100. The number of apertures 24 per square inch (or per square centimeter) controls the overall treatment area or on a micro scale the arc area. For example, as the number of apertures 24 per square inch (or per square centimeter) increases, the treatment area decreases, and vice-versa. When the tissue surface 12 is electrically conductive, the opposite is true.


Tissue contacting wall 12 of over shoe 10 has a thickness which in turn defines the thickness and/or depth of apertures 24. For a system wherein the apertures are on a micro scale, the thickness of tissue contacting wall 12 controls the system resistance and voltage needed to establish the arc. The thicker tissue contacting wall 12 the greater the system resistance and voltage needed to establish the arc, and vice-versa.


Preferably, tissue contacting wall 12 has a thickness which is predetermined during fabrication of over shoe 10 for effectively operating electrode assembly 110 of forceps 100 in one of several modes, such as seal cut, coagulate and blend, by using the electrosurgical generator. For example, it is envisioned that the tissue contacting wall 12 may have a relatively small thickness, in the range of about 10 μm to about 500 μm, is preferred for operating electrode assembly 110 of forceps 100 in a “cut” mode; tissue contacting wall 12 having a relatively medium thickness, in the range of about 250 μm to about 1 mm, is preferred for operating electrode assembly 110 of forceps 100 in a “blend” mode; and tissue contacting wall 12 having a relatively large thickness, in the range of about 500 μm to 2 mm, is preferred for operating electrode assembly 110 of forceps 100 in the “coagulate” mode.


It is envisioned that the thickness of tissue contacting wall 12 can be varied along the length and/or the width thereof in order to be able to effectively operate electrode assembly 110 of forceps 100 in more than one mode by using the electrosurgical generator at one fixed setting. For example, tissue contacting wall 12 can have a first portion having a first thickness for operating electrode assembly 110 of forceps 100 in one of the seal, cut, blend and coagulate modes and at least one second portion having a second thickness for operating electrode assembly 110 of forceps 100 in another of the seal, cut, blend and coagulate modes.


In one method of use, an over shoe 10 can be placed over each jaw member 280, 282 of forceps 100 or 200, which over shoes 10 are dimensioned in such a manner that may simultaneously effect coagulation between portions of jaw members 280, 282 and effect tissue cutting between other portions of jaw members 280, 282. More particularly, in the areas where tissue contacting walls 12 of over shoes 10 is thicker the tissue held between jaw members 280, 282 will tend to coagulate and in the areas where tissue contacting walls 12 of over shoes 10 is thinner the tissue held between jaw members 280, 282 will tend to be cut. Accordingly, as can be appreciated, a single energy activation of the electrosurgical generator may yield a dual tissue effect which greatly simplifies the coagulating and dividing of tissue.


Similarly, an over shoe may be dimensioned to seal and cut tissue by controlling the thickness of the over shoe along the length or width of each jaw member 280, 282. As can be appreciated, by utilizing a combination of controlling gap distance and sealing pressure and controlling the current to the tissue, a surgeon may simultaneously seal and cut tissue disposed between jaw members 280, 282 due to the unique configuration of the over shoe.


While the insulating type over shoe 10 has been described as being manufactured entirely of a ceramic material, it is envisioned and within the scope of the present disclosure that only tissue contacting wall 12 needs to be manufactured from a ceramic material while the remainder of over shoe 10 (e.g., side walls 14, 16 and bottom wall 18) can be manufactured from some other rigid and/or flexible non-conductive material, such as, for example, plastic, latex, silicone and the like.


Turning now to FIGS. 5-9, an over shoe in accordance with another embodiment of the present disclosure is shown generally as 10a. Over shoe 10a is substantially similar to over shoe 10 and will be discussed in detail to the extent necessary to identify differences in construction and operation. As seen in FIGS. 5-9 bottom wall 18 includes a longitudinally oriented slot 30 extending substantially the entire length of over shoe 10a. Accordingly, slot 30 enables over shoe 10a to be slipped over and onto, for example, jaw members 280, 282, having widths which are larger than the width of tissue contacting wall 12 and/or larger than the width of opening 22 formed at the proximal end thereof. In other words, as seen in FIGS. 8 and 9, slot 30 enables and/or allows side walls 14, 16 to deflect and/or bow orthogonally outward (as indicated by arrows “A”) when a jaw member 280, 282 is inserted into over shoe 10a.


Tuning now to FIG. 10, an over shoe, in accordance with yet another embodiment of the present disclosure, is shown generally as 10b. Over shoe 10b is substantially similar to over shoe 10 and will only be discussed in detail to the extent necessary to identify differences in construction and operation. As seen in FIG. 10, over shoe 10b includes at least one, preferably a pair of bands 32 secured to and extending across tissue contacting wall 12. Preferably, bands 32 are elastic and enable over shoe 10b to be slipped onto and/or into engagement with jaw members 280, 282 of varying width and/or thickness. While elastic bands 32 are preferred, it is envisioned and within the scope of the present disclosure for bands 32 to be inelastic, capable of being tied to one another and/or capable of being releasably secured to one another (e.g., hook and loop type fasteners).


Turning now to FIG. 11, an exemplary positioning arrangement for the engagement of over shoe 10 to a jaw member 280, 282 of forceps 100 or 200, is shown. As seen in FIG. 11, the inner surface of one, preferably each side wall 14, 16 of over shoe 10 includes a nub, projection or the like 34 extending therefrom. Nubs 34 preferably engage with and/or are received in corresponding recesses 283 formed in the side surfaces of jaw members 280, 282, in a snap-fit type engagement. In this manner, when over shoe 10 is slipped onto and/or over one of jaw members 280, 282 of forceps 100 or 200, the positioning arrangement fixes the location and/or position of the apertures (not shown) on jaw member 280 or 282. Meanwhile, when over shoe 10 is slipped onto and/or over the other of jaw members 280, 282 of forceps 100 or 200, the positioning arrangement fixes the location and/or position of the apertures (not shown) on the other of jaw member 280 or 282. In this manner, the position of the apertures (not shown) on jaw member 280 can be fixed and predetermined relative to the position of the apertures (not shown) on jaw member 282. For example, apertures 24 of over shoe 10 corresponding to jaw member 280 can be in juxtaposed vertical registration or in juxtaposed offset registration with apertures 24 of over shoe 10 corresponding to jaw member 282 depending on a particular purpose.


As best seen in FIG. 11, various electrical connections of electrode assemblies 110, 210 (not shown) are configured to provide electrical continuity to a series of electrode pads 290 disposed atop at least one of jaw members 280, 282 for transmitting electrosurgical energy to the tissue. When the over shoe 10 is electrically conductive, different electrical connections would obviously apply.


Turning now to FIGS. 12-15, exemplary illustrations of various arrangements and patterns of apertures 24, formed in tissue contacting wall 12, are shown for use with either an electrically conductive overshoe or an electrically insulative over shoe. As seen in FIG. 12, apertures 24 are unevenly distributed and/or formed in tissue contacting wall 12. In particular, there is shown an increased density of apertures 24 formed in both a distal region and a proximal region of tissue contacting wall 12 and a reduced density of apertures 24 formed in a central region of tissue contacting wall 12.


As seen in FIG. 13, tissue contacting wall 12 of over shoe 10 can be provided with at least two longitudinally oriented rows of alternatingly-sized apertures, namely, relatively larger sized apertures 24a and relatively smaller sized apertures 24b.


As seen in FIG. 14, tissue contacting wall 12 of over shoe 10 can be provided with at least two longitudinally-oriented, preferably offset, rows of elongate slots 24c formed therein. As seen in FIG. 15, slots 24c can be oriented at an angle with respect to a longitudinal axis of tissue contacting wall 12.


While FIGS. 12-15 illustrate exemplary arrangements and/or patterns of apertures that can be formed in tissue contacting wall 12 of over shoe 10, in no way is this to be an exhaustive illustration of all of the arrangements and/or patterns that can be formed in tissue contacting wall 12. For example, any of the arrangements and/or patterns illustrated in FIGS. 12-15 can be interchanged and/or combined with one another in any order, orientation and/or density.


As seen in FIG. 16, over shoes 10, configured and dimensioned to be slipped over jaw members 280, 282 of forceps 100, are shown in position over each jaw member 280, 282 thereof. As seen in FIG. 17, over shoes 10, configured and dimensioned to be slipped over jaw members 280, 282 of forceps 200, are shown in position over each jaw member 280, 282 thereof.


Although the majority of the figure drawings depict an over shoe for use with a bipolar forceps for use in connection with endoscopic surgical procedures, over shoes for open forceps are also contemplated for use in connection with traditional open surgical procedures.


In use, as depicted in the insulating embodiment of FIGS. 18A-18D, over shoe 10 positioned on at least one of jaw members 280, 282, the surgeon initially approximates tissue “T” (see FIG. 18A) between the opposing jaw members 280, 282 and then grasps tissue “T” (see FIG. 18B) by manipulating forceps 100 or 200 to approximate jaw members 280, 282 towards one another. Once tissue “T” is grasped, the surgeon selectively activates electrosurgical generator (see FIG. 18C) to supply electrosurgical energy to electrode pad 290 of each jaw member 280, 282. In particular, electrosurgical energy flows from the positive terminal of electrosurgical generator, to electrode pad 290 of jaw member 282, through aperture 24 of over shoe 10 placed on jaw member 282, through tissue “T”, through aperture 24 of over shoe 10 placed on jaw member 280, to electrode pad 290 of jaw member 280, and back to the negative terminal of electrosurgical generator. As a result thereof, an intermittent pattern of tissue seals and/or welds “W” are created along tissue “T” (see FIGS. 18C and 18D).


The arrangement and/or pattern of apertures 24 formed in over shoes 10 only permits the sealing and/or welding of tissue “T” which is located between juxtaposed apertures 24 of over shoes 10 placed on each jaw member 280, 282. Tissue “T” adjacent each aperture 24 remains viable which, as can be appreciated, allows blood and nutrients to flow through the sealed tissue “T” and between the individual tissue welds “W”, as indicated by arrows “F” of FIG. 18D, to promote tissue healing and reduce the chances of tissue necrosis. As mentioned above, a conductive over shoe 10 may be used to obtain a similar surgical result.


A controller “C” (see FIG. 18C) may be electrically interposed between electrosurgical generator and electrode pads 290 to regulate the electrosurgical energy supplied thereto depending upon certain electrical parameters, such as, for example, current impedance, temperature, voltage, tissue type, tissue thickness, etc. For example, the forceps or controller “C” may include one or more sensors and/or smart sensors (not shown) which communicate with electrosurgical generator (or with a smart circuit, a computer, a feedback loop, etc.) to automatically regulate the electrosurgical intensity (e.g., waveform, current, voltage, etc.) to enhance the sealing and/or welding process. The sensors may measure or monitor one or more of the following parameters: tissue temperature, tissue impedance at the weld site, the change in impedance of the tissue over time and/or changes in power or current applied in the tissue over time. An audible or visual feedback monitor (not shown) may be employed to convey to the surgeon regarding the overall seal quality of the completion of an effective tissue seal.


Moreover, a PCB (printed circuit board) circuit or flex circuit (not shown) may be utilized to provide information relating to the gap distance (e.g., with a proximity detector) between jaw members 280, 282, the sealing pressure between jaw members 280, 282 prior to and during activation, load (e.g., with a strain gauge), the thickness of tissue “T” prior to or during activation, the impedance across the tissue during activation, and the rate of tissue expansion during activation and sealing.


Several examples of such devices and systems are described in commonly-owned U.S. application Ser. No. 10/427,832 the entire contents of which are hereby incorporated by reference herein. Methods and systems for adjusting and setting the gap distance are also disclosed in commonly assigned U.S. Provisional Patent Application Ser. No. 60/470,632, the entire contents also being hereby incorporated by reference herein. Methods and systems for controlling the output of RF medical generators are disclosed in commonly assigned U.S. patent application Ser. No. 10/417,823, the entire contents being hereby incorporated by reference herein.


It is envisioned that the PCB circuit may be designed to provide electrical feedback to electrosurgical generator relating to one or more of the above parameters either on a continuous basis or upon inquiry from electrosurgical generator. For example, a PCB circuit may be employed to control the power, current and/or type of current waveform delivered from electrosurgical generator to jaw members 280, 282 in order to reduce collateral damage to surrounding tissue during activation, e.g., thermal spread, tissue vaporization and/or steam from the treatment site. Examples of various control circuits, generators and algorithms which may be utilized are disclosed in U.S. Pat. No. 6,228,080 and U.S. patent application Ser. No. 10/073,761, the entire contents of both of which are hereby incorporated by reference herein.


From the foregoing and with reference to the various figure drawings, those skilled in the art will appreciate that certain modifications can also be made to the present disclosure without departing from the scope of the same. For example, it is envisioned that the diameter of the apertures of the over shoe may be varied during the manufacturing process of the over shoe according to the type of surgical instrument to be used. In particular, it is envisioned that one sized aperture diameter may be used for electrosurgical blades for coagulating or cutting tissue while another aperture diameter may be used for electrosurgical forceps which utilize a combination of closing force, gap distance between jaw members and amount of electrosurgical energy, to seal tissue.


Moreover, it is envisioned that the number of apertures per square inch (or per square centimeter) may be modified during the manufacturing process to control the treatment area and minimize the collateral effect to surrounding tissue. In addition, as discussed above, the shape of the apertures include and are not limited to circular, triangular, rectangular, oval and the like. It is also contemplated that the thickness of the tissue contacting wall 12 of the over shoe 10 may be modified during the manufacturing process to establish a preferred resistance and voltage for creating a desired surgical effect.


As mentioned repeatedly above, it is further envisioned that the jaw members 280, 282 of forceps 100 can be insulative and that an over shoe 10, or preferably, tissue contacting wall 12 of over shoe 10, is fabricated from a conductive material and electrically connected to an electrosurgical energy source (See FIG. 19A). In this manner, any non-electrosurgical forceps can be retrofitted with over shoe 10 placed on or slipped over at least one of its jaw members. Apertures 24 of over shoe 10 in turn act as cooling spots (i.e., regions where limited electrosurgical energy or thermal energy is transmitted). In this manner, following use and application of electrosurgical energy to tissue “T”, the regions where over shoe 10 contacts tissue “T” is where tissue sealing and/or welding occurs and the regions where apertures 24 are located do not experience tissue sealing and/or welding and remain viable tissue. As can be appreciated, each over shoe would be attachable to a different electrical potential emanating from an electrosurgical generator such that the over shoes are capable of conducting bipolar electrosurgical energy through tissue held therebetween. As such, wires or conductive elements 25 would be used to accomplish this purpose.


As best seen in FIG. 19B, it is also contemplated that over shoe 10 can include electrically conductive tissue contacting portions 27 or projections in lieu of apertures 24. For example, tissue contacting wall 12a and/or electrically conductive tissue contacting portions 27 may be arranged on surface 12a to project therefrom to create a pattern of tissue welds for treating tissue. It is also envisioned that the projections 27 can be coated with non-stick materials. When utilized on these surfaces, the non-stick materials provide an optimal surface energy for eliminating sticking due in part to the surface texture and the susceptibility to surface breakdown due to electrical effects and corrosion in the presence of biologic tissues. As can be appreciated, reducing the amount that the tissue “sticks” during sealing improves the overall efficacy of the instrument.


The non-stick materials may be manufactured from one (or a combination of one or more) of the following “non-stick” materials, namely, nickel-chrome, chromium nitride, MedCoat 2000 manufactured by The Electrolizing Corporation of OHIO, Inconel 600 and tin-nickel. Inconel 600 is a so-called “super alloy” which is manufactured by Special Metals, Inc. located in Conroe Tex. Super alloys are primarily used in environments which require resistance to corrosion and heat. The high Nickel content of Inconel 600 makes the material especially resistant to organic corrosion. As can be appreciated, these properties are desirable for bipolar electrosurgical instruments which are naturally exposed to high temperatures, high RF energy and organic matter.


One particular class of materials disclosed herein has demonstrated superior non-stick properties and, in some instances, superior micro-seal quality. For example, nitride coatings which include, but not are not limited to: TiN, ZrN, TiAlN, and CrN are preferred materials used for non-stick purposes. CrN has been found to be particularly useful for non-stick purposes due to its overall surface properties and optimal performance. Other classes of materials have also been found to reduce overall sticking. For example, high nickel/chrome alloys with a Ni/Cr ratio of approximately 5:1 have been found to significantly reduce sticking in bipolar instrumentation.


While the above disclosure and figures relate to hemostats, forceps or bipolar instruments, it is contemplated and within the scope of the present disclosure that the over shoes disclosed herein can be used in connection with and/or association with electrosurgical pencils and the like.


Although the present disclosure has been described with respect to particular embodiments, it will be readily apparent to those having ordinary skill in the art to which it pertains, that changes and modifications may be made thereto without departing from the spirit or scope of the disclosure.

Claims
  • 1. An over shoe selectively positionable on at least one jaw member of an electrosurgical instrument, the over shoe comprising: a tissue contacting wall configured to overlay a tissue contacting surface of the at least one jaw member and having at least one aperture defined therein;a first wall engaged with the tissue contacting wall; anda second wall engaged with at least one of the tissue contacting wall or the first wall;wherein inner surfaces of the tissue contacting wall, the first wall, and the second wall are configured to frictionally retain the over shoe on the at least one jaw member of the electrosurgical instrument.
  • 2. The over shoe according to claim 1, wherein the tissue contacting wall is substantially planar.
  • 3. The over shoe according to claim 1, wherein the at least one aperture includes at least two apertures, and wherein each aperture is evenly sized.
  • 4. The over shoe according to claim 1, wherein each aperture of the at least one aperture is circular.
  • 5. The over shoe according to claim 4, wherein each aperture has a diameter of between 10 μm and 1000 μm.
  • 6. The overshoe according to claim 1, wherein each aperture of the plurality of apertures is an elongated slot.
  • 7. The over shoe according to claim 1, wherein the tissue contacting wall is formed from a conductive material.
  • 8. The over shoe according to claim 1, wherein the tissue contacting wall is formed from a non-conductive material.
  • 9. The over shoe according to claim 1, further comprising a protrusion extending from the tissue contacting wall and configured to electrically communicate with an electrode of a first jaw member of the at least one jaw member when the overshoe is selectively positioned on the first jaw member.
  • 10. The over shoe according to claim 9, wherein the protrusion is configured to create a pattern of tissue welds for treating tissue.
  • 11. The over shoe according to claim 9, wherein the protrusion is coated with a non-stick material, wherein the non-stick material is selected from the group consisting of nickel-chrome, chromium nitride and tin-nickel.
  • 12. The over shoe according to claim 1, further comprising a longitudinally oriented slot defined in the second wall.
  • 13. An over shoe selectively positionable on at least one jaw member of an electrosurgical instrument, the over shoe comprising: a material configured to overlay a tissue-contacting surface of at least one jaw member of the electrosurgical instrument, the material having a tissue-contacting wall and an inner surface, the material including at least one aperture extending between the tissue-contacting wall and the inner surface;wherein the inner surface of the tissue-contacting wall is configured to frictionally retain the over shoe on the at least one jaw member of the least one jaw member of the electrosurgical instrument.
  • 14. The over shoe according to claim 13, wherein the material is a conductive material.
  • 15. The over shoe according to claim 13, wherein the at least one aperture includes at least two apertures, and wherein each aperture is evenly sized.
  • 16. The over shoe according to claim 9, wherein the protrusion is coated with a non-stick material including nickel-chrome.
CROSS-REFERENCE TO RELATED APPLICATION

The present application is a Continuation Application claiming the benefit of and priority to U.S. patent application Ser. No. 12/212,780, which is a Divisional Application claiming the benefit of and priority to U.S. patent application Ser. No. 10/718,379, now U.S. Pat. No. 7,442,193, filed on Nov. 20, 2003, the entire content of each of which is incorporated herein by reference.

US Referenced Citations (886)
Number Name Date Kind
371664 Brannan et al. Oct 1887 A
702472 Pignolet Jun 1902 A
728883 Downes May 1903 A
1586645 Bierman Jun 1926 A
1813902 Bovie Jul 1931 A
1822330 Ainslie Sep 1931 A
1852542 Sovatkin Apr 1932 A
2002594 Wappler et al. May 1935 A
2011169 Wappler Aug 1935 A
2031682 Wappler et al. Feb 1936 A
2054149 Wappler Sep 1936 A
2176479 Willis Oct 1939 A
2225138 Traylor, Jr. Dec 1940 A
2279753 Knopp Apr 1942 A
2305156 Grubel Dec 1942 A
2327353 Karle Aug 1943 A
2632661 Cristofv Mar 1953 A
2668538 Baker Feb 1954 A
2796065 Kapp Jun 1957 A
3073311 Tibbs et al. Jan 1963 A
3372288 Wigington Mar 1968 A
3459187 Pallotta Aug 1969 A
3643663 Sutter Feb 1972 A
3648001 Anderson et al. Mar 1972 A
3651811 Hildebrandt et al. Mar 1972 A
3678229 Osika Jul 1972 A
3720896 Beierlein Mar 1973 A
3763726 Hildebrand Oct 1973 A
3779918 Ikeda et al. Dec 1973 A
3801766 Morrison, Jr. Apr 1974 A
3862630 Balamuth Jan 1975 A
3863339 Reaney et al. Feb 1975 A
3866610 Kletschka Feb 1975 A
3911766 Fridolph et al. Oct 1975 A
3920021 Hiltebrandt Nov 1975 A
3921641 Hulka Nov 1975 A
3938527 Rioux et al. Feb 1976 A
3952749 Fridolph et al. Apr 1976 A
3970088 Morrison Jul 1976 A
3987795 Morrison Oct 1976 A
4005714 Hiltebrandt Feb 1977 A
4016881 Rioux et al. Apr 1977 A
4041952 Morrison, Jr. et al. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4074718 Morrison, Jr. Feb 1978 A
4076028 Simmons Feb 1978 A
4080820 Allen Mar 1978 A
4088134 Mazzariello May 1978 A
4112950 Pike Sep 1978 A
4127222 Adams Nov 1978 A
4128099 Bauer Dec 1978 A
4165746 Burgin Aug 1979 A
4187420 Piber Feb 1980 A
4233734 Bies Nov 1980 A
4236470 Stenson Dec 1980 A
4300564 Furihata Nov 1981 A
4311145 Esty et al. Jan 1982 A
D263020 Rau, III Feb 1982 S
4370980 Lottick Feb 1983 A
4375218 Digeronimo Mar 1983 A
4416276 Newton et al. Nov 1983 A
4418692 Guay Dec 1983 A
4443935 Zamba et al. Apr 1984 A
4452246 Bader et al. Jun 1984 A
4470786 Sano et al. Sep 1984 A
4492231 Auth Jan 1985 A
4493320 Treat Jan 1985 A
4503855 Maslanka Mar 1985 A
4506669 Blake, III Mar 1985 A
4509518 McGarry et al. Apr 1985 A
4552143 Lottick Nov 1985 A
4574804 Kurwa Mar 1986 A
4597379 Kihn et al. Jul 1986 A
4600007 Lahodny et al. Jul 1986 A
4624254 McGarry et al. Nov 1986 A
4655215 Pike Apr 1987 A
4655216 Tischer Apr 1987 A
4657016 Garito et al. Apr 1987 A
4662372 Sharkany et al. May 1987 A
4671274 Sorochenko Jun 1987 A
4685459 Koch et al. Aug 1987 A
4733662 DeSatnick et al. Mar 1988 A
D295893 Sharkany et al. May 1988 S
D295894 Sharkany et al. May 1988 S
4754892 Retief Jul 1988 A
4763669 Jaeger Aug 1988 A
4826338 Kilpatrick May 1989 A
4827929 Hodge May 1989 A
4829313 Taggart May 1989 A
4846171 Kauphusman et al. Jul 1989 A
4887612 Esser et al. Dec 1989 A
4938761 Ensslin Jul 1990 A
4947009 Osika et al. Aug 1990 A
4985030 Melzer et al. Jan 1991 A
5007908 Rydell Apr 1991 A
5026370 Lottick Jun 1991 A
5026371 Rydell et al. Jun 1991 A
5035695 Weber, Jr. et al. Jul 1991 A
5037433 Wilk et al. Aug 1991 A
5042707 Taheri Aug 1991 A
5047046 Bodoia Sep 1991 A
5078716 Doll Jan 1992 A
5084057 Green et al. Jan 1992 A
5085659 Rydell Feb 1992 A
5099840 Goble et al. Mar 1992 A
5100430 Avellanet et al. Mar 1992 A
5108392 Spingler Apr 1992 A
5112343 Thornton May 1992 A
5116332 Lottick May 1992 A
5147357 Rose et al. Sep 1992 A
5151102 Kamiyarna et al. Sep 1992 A
5151978 Bronikowski et al. Sep 1992 A
5176695 Dulebohn Jan 1993 A
5190541 Abele et al. Mar 1993 A
5196009 Kirwan, Jr. Mar 1993 A
5197964 Parins Mar 1993 A
5209747 Knoepfler May 1993 A
5211655 Hasson May 1993 A
5215101 Jacobs et al. Jun 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217458 Parins Jun 1993 A
5217460 Knoepfler Jun 1993 A
5219354 Choudhury et al. Jun 1993 A
5244462 Delahuerga et al. Sep 1993 A
5250047 Rydell Oct 1993 A
5250063 Abidin et al. Oct 1993 A
5258001 Corman Nov 1993 A
5258006 Rydell et al. Nov 1993 A
5261918 Phillips et al. Nov 1993 A
5275615 Rose Jan 1994 A
5277201 Stern Jan 1994 A
5282799 Rydell Feb 1994 A
5282800 Foshee et al. Feb 1994 A
5282826 Quadri Feb 1994 A
5290286 Parins Mar 1994 A
5300082 Sharpe et al. Apr 1994 A
5304203 El-Mallawany et al. Apr 1994 A
5308353 Beurrier May 1994 A
5308357 Lichtman May 1994 A
5313027 Inoue et al. May 1994 A
5314445 Heidmueller nee Degwitz et al. May 1994 A
5318589 Lichtman Jun 1994 A
5324289 Eggers Jun 1994 A
D348930 Olson Jul 1994 S
5326806 Yokoshima et al. Jul 1994 A
5330471 Eggers Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5334183 Wuchinich Aug 1994 A
5334215 Chen Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5336221 Anderson Aug 1994 A
5342359 Rydell Aug 1994 A
5342381 Tidemand Aug 1994 A
5342393 Stack Aug 1994 A
5344424 Roberts et al. Sep 1994 A
5350391 Iacovelli Sep 1994 A
5352222 Rydell Oct 1994 A
5354271 Voda Oct 1994 A
5356408 Rydell Oct 1994 A
5366477 LeMarie, III et al. Nov 1994 A
5368600 Failla et al. Nov 1994 A
5374277 Hassler Dec 1994 A
5376089 Smith Dec 1994 A
5383875 Bays et al. Jan 1995 A
5383897 Wholey Jan 1995 A
5389098 Tsuruta et al. Feb 1995 A
5389103 Melzer et al. Feb 1995 A
5389104 Hahnen et al. Feb 1995 A
5391166 Eggers Feb 1995 A
5391183 Janzen et al. Feb 1995 A
5396900 Slater et al. Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403342 Tovey et al. Apr 1995 A
5405344 Williamson et al. Apr 1995 A
5409763 Serizawa et al. Apr 1995 A
5411519 Tovey et al. May 1995 A
5411520 Nash et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5415656 Tihon et al. May 1995 A
5415657 Taymor-Luria May 1995 A
5422567 Matsunaga Jun 1995 A
5423810 Goble et al. Jun 1995 A
5425690 Chang Jun 1995 A
5425739 Jessen Jun 1995 A
5429616 Schaffer Jul 1995 A
5431672 Cote et al. Jul 1995 A
5431674 Basile et al. Jul 1995 A
5437292 Kipshidze et al. Aug 1995 A
5438302 Goble Aug 1995 A
5439478 Palmer Aug 1995 A
5441517 Kensey et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5443464 Russell et al. Aug 1995 A
5443480 Jacobs et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5445658 Durrfeld et al. Aug 1995 A
5449480 Kuriya et al. Sep 1995 A
5451224 Goble et al. Sep 1995 A
5454823 Richardson et al. Oct 1995 A
5454827 Aust et al. Oct 1995 A
5456684 Schmidt et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5460629 Shlain et al. Oct 1995 A
5461765 Linden et al. Oct 1995 A
5462546 Rydell Oct 1995 A
5472442 Klicek Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5478351 Meade et al. Dec 1995 A
5480406 Nolan et al. Jan 1996 A
5480409 Riza Jan 1996 A
5484436 Eggers et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5496347 Hashiguchi et al. Mar 1996 A
5499997 Sharpe et al. Mar 1996 A
5509922 Aranyi et al. Apr 1996 A
5512721 Young et al. Apr 1996 A
5514134 Rydell et al. May 1996 A
5527313 Scott et al. Jun 1996 A
5528833 Sakuma Jun 1996 A
5529067 Larsen et al. Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5536251 Evard et al. Jul 1996 A
5540684 Hassler, Jr. Jul 1996 A
5540685 Parins et al. Jul 1996 A
5540706 Aust et al. Jul 1996 A
5540715 Katsaros et al. Jul 1996 A
5542945 Fritzsch Aug 1996 A
5558671 Yates Sep 1996 A
5558672 Edwards et al. Sep 1996 A
5562619 Mirarchi et al. Oct 1996 A
5562699 Heimberger et al. Oct 1996 A
5562720 Stern et al. Oct 1996 A
5564615 Bishop et al. Oct 1996 A
5569241 Edwards Oct 1996 A
5569243 Kortenbach et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5573424 Poppe Nov 1996 A
5573534 Stone Nov 1996 A
5573535 Viklund Nov 1996 A
5575799 Bolanos et al. Nov 1996 A
5575805 Li Nov 1996 A
5578052 Koros et al. Nov 1996 A
5579781 Cooke Dec 1996 A
5582611 Tsuruta et al. Dec 1996 A
5582617 Klieman et al. Dec 1996 A
5585896 Yamazaki et al. Dec 1996 A
5590570 LeMaire, III et al. Jan 1997 A
5591181 Stone et al. Jan 1997 A
5597107 Knodel et al. Jan 1997 A
5601224 Bishop et al. Feb 1997 A
5601601 Tal et al. Feb 1997 A
5601641 Stephens Feb 1997 A
5603711 Parins et al. Feb 1997 A
5603723 Aranyi et al. Feb 1997 A
5611798 Eggers Mar 1997 A
5611808 Hossain et al. Mar 1997 A
5611813 Lichtman Mar 1997 A
5620415 Lucey et al. Apr 1997 A
5620453 Nallakrishnan Apr 1997 A
5620459 Lichtman Apr 1997 A
5624452 Yates Apr 1997 A
5626578 Tihon May 1997 A
5626609 Zvenyatsky et al. May 1997 A
5630833 Katsaros et al. May 1997 A
5637110 Pennybacker et al. Jun 1997 A
5638003 Hall Jun 1997 A
5643294 Tovey et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5647871 Levine et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
5655650 Naitou Aug 1997 A
5658281 Heard Aug 1997 A
D384413 Zlock et al. Sep 1997 S
5662667 Knodel Sep 1997 A
5665100 Yoon Sep 1997 A
5667526 Levin Sep 1997 A
5674220 Fox Oct 1997 A
5674229 Tovey et al. Oct 1997 A
5681282 Eggers et al. Oct 1997 A
5688270 Yates et al. Nov 1997 A
5690652 Wurster et al. Nov 1997 A
5690653 Richardson et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5693920 Maeda Dec 1997 A
5695522 LeMaire, III et al. Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5700270 Peyser et al. Dec 1997 A
5702390 Austin et al. Dec 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5713895 Lontine Feb 1998 A
5716366 Yates Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
5722421 Francese et al. Mar 1998 A
5725536 Oberlin et al. Mar 1998 A
5727428 LeMaire, III et al. Mar 1998 A
H1745 Paraschac Apr 1998 H
5735848 Yates et al. Apr 1998 A
5743906 Parins et al. Apr 1998 A
5752973 Kieturakis May 1998 A
5755717 Yates et al. May 1998 A
5759188 Yoon Jun 1998 A
5762435 Fukushima Jun 1998 A
5766130 Selmonosky Jun 1998 A
5766166 Hooven Jun 1998 A
5766170 Eggers Jun 1998 A
5766196 Griffiths Jun 1998 A
5769849 Eggers Jun 1998 A
5772655 Bauer et al. Jun 1998 A
5772670 Brosa Jun 1998 A
5776128 Eggers Jul 1998 A
5776130 Buysse et al. Jul 1998 A
5779646 Koblish et al. Jul 1998 A
5779701 McBrayer et al. Jul 1998 A
5792137 Carr et al. Aug 1998 A
5792165 Kiernan et al. Aug 1998 A
5792177 Kaseda Aug 1998 A
5797537 Oberlin et al. Aug 1998 A
5797927 Yoon Aug 1998 A
5797938 Paraschac et al. Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5797958 Yoon Aug 1998 A
5800449 Wales Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5810805 Sutcu et al. Sep 1998 A
5810808 Eggers Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810877 Roth et al. Sep 1998 A
5814043 Shapeton Sep 1998 A
5814054 Kortenbach et al. Sep 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5820630 Lind Oct 1998 A
5824978 Karasik et al. Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827279 Hughett et al. Oct 1998 A
5827281 Levin Oct 1998 A
5827323 Klieman et al. Oct 1998 A
5827548 Lavallee et al. Oct 1998 A
5833690 Yates et al. Nov 1998 A
5843080 Fleenor et al. Dec 1998 A
5849022 Sakashita et al. Dec 1998 A
5853412 Mayenberger Dec 1998 A
5859527 Cook Jan 1999 A
5860976 Billings et al. Jan 1999 A
5876401 Schulze et al. Mar 1999 A
5876412 Piraka Mar 1999 A
5882567 Cavallaro et al. Mar 1999 A
5891141 Rydell Apr 1999 A
5891142 Eggers et al. Apr 1999 A
5893863 Yoon Apr 1999 A
5893875 O'Connor et al. Apr 1999 A
5893877 Garnpp, Jr. et al. Apr 1999 A
5897563 Yoon et al. Apr 1999 A
5902301 Olig May 1999 A
5906630 Anderhub et al. May 1999 A
5908420 Parins et al. Jun 1999 A
5908432 Pan Jun 1999 A
5911719 Eggers Jun 1999 A
5913874 Berns et al. Jun 1999 A
5921916 Aeikens et al. Jul 1999 A
5921984 Sutcu et al. Jul 1999 A
5925043 Kumar et al. Jul 1999 A
5928136 Barry Jul 1999 A
5935126 Riza Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5944718 Austin et al. Aug 1999 A
5951546 Lorentzen Sep 1999 A
5951549 Richardson et al. Sep 1999 A
5954720 Wilson et al. Sep 1999 A
5954731 Yoon Sep 1999 A
5954733 Yoon Sep 1999 A
5957923 Hahnen et al. Sep 1999 A
5957937 Yoon Sep 1999 A
5960544 Beyers Oct 1999 A
5961514 Long et al. Oct 1999 A
5964758 Dresden Oct 1999 A
5976132 Morris Nov 1999 A
5984932 Yoon Nov 1999 A
5984938 Yoon Nov 1999 A
5984939 Yoon Nov 1999 A
5989277 LeMaire, III et al. Nov 1999 A
5993466 Yoon Nov 1999 A
5993467 Yoon Nov 1999 A
5997565 Inoue Dec 1999 A
6004332 Yoon et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6010516 Hulka Jan 2000 A
6017358 Yoon et al. Jan 2000 A
6021693 Feng-Sing Feb 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024743 Edwards Feb 2000 A
6024744 Kese et al. Feb 2000 A
6027522 Palmer Feb 2000 A
6030384 Nezhat Feb 2000 A
6033399 Gines Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6041679 Slater et al. Mar 2000 A
6050996 Schmaltz et al. Apr 2000 A
6053914 Eggers et al. Apr 2000 A
6053933 Balazs et al. Apr 2000 A
D424694 Tetzlaff et al. May 2000 S
D425201 Tetzlaff et al. May 2000 S
6059782 Novak et al. May 2000 A
6066139 Ryan et al. May 2000 A
6074386 Goble et al. Jun 2000 A
6077287 Taylor et al. Jun 2000 A
6080180 Yoon et al. Jun 2000 A
RE36795 Rydell Jul 2000 E
6083223 Baker Jul 2000 A
6086586 Hooven Jul 2000 A
6086601 Yoon Jul 2000 A
6090107 Borgmeier et al. Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6102909 Chen et al. Aug 2000 A
6106542 Toybin et al. Aug 2000 A
6110171 Rydell Aug 2000 A
6113596 Hooven et al. Sep 2000 A
6113598 Baker Sep 2000 A
6117158 Measamer et al. Sep 2000 A
6122549 Sharkey et al. Sep 2000 A
6123701 Nezhat Sep 2000 A
H1904 Yates et al. Oct 2000 H
6126658 Baker Oct 2000 A
6126665 Yoon Oct 2000 A
6139563 Cosgrove et al. Oct 2000 A
6143005 Yoon et al. Nov 2000 A
6152923 Ryan Nov 2000 A
6162220 Nezhat Dec 2000 A
6171316 Kovac et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6178628 Clemens et al. Jan 2001 B1
6179834 Buysse et al. Jan 2001 B1
6179837 Hooven Jan 2001 B1
6183467 Shapeton et al. Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6190400 Van De Moer et al. Feb 2001 B1
6193718 Kortenbach et al. Feb 2001 B1
6206876 Levine et al. Mar 2001 B1
6206877 Kese et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6214028 Yoon et al. Apr 2001 B1
6217602 Redman Apr 2001 B1
6217615 Sioshansi et al. Apr 2001 B1
6221039 Durgin et al. Apr 2001 B1
6223100 Green Apr 2001 B1
6224593 Ryan et al. May 2001 B1
6224614 Yoon May 2001 B1
6228080 Gines May 2001 B1
6228083 Lands et al. May 2001 B1
6248124 Pedros et al. Jun 2001 B1
6248944 Ito Jun 2001 B1
6261307 Yoon et al. Jul 2001 B1
6267761 Ryan Jul 2001 B1
6270497 Sekino et al. Aug 2001 B1
6270508 Klieman et al. Aug 2001 B1
6273887 Yamauchi et al. Aug 2001 B1
6277117 Tetzlaff Aug 2001 B1
6280458 Bache et al. Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
D449886 Tetzlaff et al. Oct 2001 S
6298550 Kirwan, Jr. Oct 2001 B1
6302424 Gisinger et al. Oct 2001 B1
6319262 Bates et al. Nov 2001 B1
6319451 Brune Nov 2001 B1
6322561 Eggers et al. Nov 2001 B1
6322580 Kanner Nov 2001 B1
6325795 Lindemann et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6334861 Chandler et al. Jan 2002 B1
6345532 Coudray et al. Feb 2002 B1
6350264 Hooven Feb 2002 B1
6352536 Buysse et al. Mar 2002 B1
6358249 Chen et al. Mar 2002 B1
6358259 Swain et al. Mar 2002 B1
6358268 Hunt et al. Mar 2002 B1
6364879 Chen et al. Apr 2002 B1
D457958 Dycus et al. May 2002 S
D457959 Tetzlaff et al. May 2002 S
6387094 Eitenmuller May 2002 B1
6391035 Appleby et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6402747 Lindemann et al. Jun 2002 B1
6409728 Ehr et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6419675 Gallo, Sr. Jul 2002 B1
6425896 Baltschun et al. Jul 2002 B1
6432112 Brock et al. Aug 2002 B2
6440144 Bacher Aug 2002 B1
6443952 Mulier et al. Sep 2002 B1
6443970 Schulze et al. Sep 2002 B1
6451018 Lands et al. Sep 2002 B1
6458125 Cosmescu Oct 2002 B1
6458128 Schulze Oct 2002 B1
6458130 Frazier et al. Oct 2002 B1
6461352 Morgan et al. Oct 2002 B2
6461368 Fogarty et al. Oct 2002 B2
6464701 Hooven et al. Oct 2002 B1
6464702 Schulze et al. Oct 2002 B2
6464704 Schmaltz et al. Oct 2002 B2
6485489 Teirstein et al. Nov 2002 B2
6494888 Laufer et al. Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6506196 Laufer Jan 2003 B1
6508815 Strul et al. Jan 2003 B1
6511480 Tetzlaff et al. Jan 2003 B1
6514215 Ouchi Feb 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6517539 Smith et al. Feb 2003 B1
6527771 Weadock et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6545239 Spedale et al. Apr 2003 B2
6558385 McClurken et al. May 2003 B1
6562037 Paton et al. May 2003 B2
6569105 Kortenbach et al. May 2003 B1
6582450 Ouchi Jun 2003 B2
6585735 Frazier et al. Jul 2003 B1
6602252 Mollenauer Aug 2003 B2
6605790 Yoshida Aug 2003 B2
6616658 Ineson Sep 2003 B2
6616661 Wellman et al. Sep 2003 B2
6620161 Schulze et al. Sep 2003 B2
6620184 de Laforcade et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6638287 Danitz et al. Oct 2003 B2
6641595 Moran et al. Nov 2003 B1
6652514 Ellman et al. Nov 2003 B2
6652521 Schulze Nov 2003 B2
6656175 Francischelli et al. Dec 2003 B2
6656177 Truckai et al. Dec 2003 B2
6660072 Chatterjee Dec 2003 B2
6663639 Laufer et al. Dec 2003 B1
6663641 Kovac et al. Dec 2003 B1
6666854 Lange Dec 2003 B1
6669696 Bacher et al. Dec 2003 B2
6673092 Bacher Jan 2004 B1
6676660 Wampler et al. Jan 2004 B2
6676676 Danitz et al. Jan 2004 B2
6679882 Kornerup Jan 2004 B1
6682527 Strul Jan 2004 B2
6682528 Frazier et al. Jan 2004 B2
6685724 Haluck Feb 2004 B1
6689131 McClurken Feb 2004 B2
6692445 Roberts et al. Feb 2004 B2
6693246 Rudolph et al. Feb 2004 B1
6695840 Schulze Feb 2004 B2
6702810 McClurken et al. Mar 2004 B2
6723092 Brown et al. Apr 2004 B2
6726068 Miller Apr 2004 B2
6726686 Buysse et al. Apr 2004 B2
6726694 Blatter et al. Apr 2004 B2
6733498 Paton et al. May 2004 B2
6736813 Yamauchi et al. May 2004 B2
6743229 Buysse et al. Jun 2004 B2
6743230 Lutze et al. Jun 2004 B2
6743239 Kuehn et al. Jun 2004 B1
6743240 Smith et al. Jun 2004 B2
6755843 Chung et al. Jun 2004 B2
6756553 Yamaguchi et al. Jun 2004 B1
6757977 Dambal et al. Jul 2004 B2
D493888 Reschke Aug 2004 S
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773432 Clayman et al. Aug 2004 B1
6773434 Ciarrocca Aug 2004 B2
6773441 Laufer et al. Aug 2004 B1
6775575 Bommannan et al. Aug 2004 B2
6776780 Mulier et al. Aug 2004 B2
6786905 Swanson et al. Sep 2004 B2
6790217 Schulze et al. Sep 2004 B2
6796981 Wham et al. Sep 2004 B2
D496997 Dycus et al. Oct 2004 S
6800825 Sasaki et al. Oct 2004 B1
6802843 Truckai et al. Oct 2004 B2
6808525 Latterell et al. Oct 2004 B2
D499181 Dycus et al. Nov 2004 S
6818000 Muller et al. Nov 2004 B2
6821285 Laufer et al. Nov 2004 B2
6835200 Laufer et al. Dec 2004 B2
6857357 Fujii Feb 2005 B2
6860880 Treat et al. Mar 2005 B2
6887240 Lands et al. May 2005 B1
6889116 Jinno May 2005 B2
6914201 Van Vooren et al. Jul 2005 B2
6926716 Baker et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6932816 Phan Aug 2005 B2
6934134 Mori et al. Aug 2005 B2
6936061 Sasaki Aug 2005 B2
D509297 Wells Sep 2005 S
6942662 Goble et al. Sep 2005 B2
6943311 Miyako Sep 2005 B2
6953430 Kidooka Oct 2005 B2
6953461 McClurken et al. Oct 2005 B2
6958070 Witt et al. Oct 2005 B2
6960210 Lands et al. Nov 2005 B2
6964662 Kidooka Nov 2005 B2
6966907 Goble Nov 2005 B2
6972017 Smith et al. Dec 2005 B2
6977495 Donofrio Dec 2005 B2
6979786 Aukland et al. Dec 2005 B2
6981628 Wales Jan 2006 B2
6987244 Bauer Jan 2006 B2
6994707 Ellman et al. Feb 2006 B2
6994709 Lida Feb 2006 B2
6997931 Sauer et al. Feb 2006 B2
7001381 Harano et al. Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7033354 Keppel Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7041102 Truckai et al. May 2006 B2
7044948 Keppel May 2006 B2
7052489 Griego et al. May 2006 B2
7052496 Yamauchi May 2006 B2
7063715 Onuki et al. Jun 2006 B2
D525361 Hushka Jul 2006 S
7070597 Truckai et al. Jul 2006 B2
7083618 Couture et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7083620 Jahns et al. Aug 2006 B2
7087051 Bourne et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090689 Nagase et al. Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101372 Dycus et al. Sep 2006 B2
7101373 Dycus et al. Sep 2006 B2
7103947 Sartor et al. Sep 2006 B2
7107124 Green Sep 2006 B2
7112199 Cosmescu Sep 2006 B2
D531311 Guerra et al. Oct 2006 S
7115123 Knowlton et al. Oct 2006 B2
7118570 Tetzlaff et al. Oct 2006 B2
7118587 Dycus et al. Oct 2006 B2
7131860 Sartor et al. Nov 2006 B2
7131970 Moses et al. Nov 2006 B2
7131971 Dycus et al. Nov 2006 B2
7135020 Lawes et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
D533942 Kerr et al. Dec 2006 S
7145757 Shea et al. Dec 2006 B2
7147638 Chapman et al. Dec 2006 B2
7150097 Sremcich et al. Dec 2006 B2
7150749 Dycus et al. Dec 2006 B2
7153314 Laufer et al. Dec 2006 B2
D535027 James et al. Jan 2007 S
7156842 Sartor et al. Jan 2007 B2
7156846 Dycus et al. Jan 2007 B2
7160298 Lawes et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7179255 Lettice et al. Feb 2007 B2
7179258 Buysse et al. Feb 2007 B2
7195631 Dumbauld Mar 2007 B2
D541418 Schechter et al. Apr 2007 S
7207990 Lands et al. Apr 2007 B2
D541938 Kerr et al. May 2007 S
7223264 Daniel et al. May 2007 B2
7223265 Keppel May 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7241288 Braun Jul 2007 B2
7241296 Buysse et al. Jul 2007 B2
7244257 Podhajsky et al. Jul 2007 B2
7246734 Shelton, IV Jul 2007 B2
7248944 Green Jul 2007 B2
7252667 Moses et al. Aug 2007 B2
7255697 Dycus et al. Aug 2007 B2
7267677 Johnson et al. Sep 2007 B2
7270660 Ryan Sep 2007 B2
7270664 Johnson et al. Sep 2007 B2
7276068 Johnson et al. Oct 2007 B2
7298973 Ovadia et al. Nov 2007 B2
7300435 Wham et al. Nov 2007 B2
7303557 Wham et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7314471 Holman Jan 2008 B2
7318823 Sharps et al. Jan 2008 B2
7329256 Johnson et al. Feb 2008 B2
7329257 Kanehira et al. Feb 2008 B2
D564662 Moses et al. Mar 2008 S
7338526 Steinberg Mar 2008 B2
7342754 Fitzgerald et al. Mar 2008 B2
7344268 Jigamian Mar 2008 B2
D567943 Moses et al. Apr 2008 S
7367976 Lawes et al. May 2008 B2
7377920 Buysse et al. May 2008 B2
7384420 Dycus et al. Jun 2008 B2
7384421 Hushka Jun 2008 B2
7396336 Orszulak et al. Jul 2008 B2
D575395 Hushka Aug 2008 S
D575401 Hixson et al. Aug 2008 S
7435249 Buysse et al. Oct 2008 B2
7442193 Shields et al. Oct 2008 B2
7442194 Dumbauld et al. Oct 2008 B2
7445621 Dumbauld et al. Nov 2008 B2
7458972 Keppel Dec 2008 B2
7473253 Dycus et al. Jan 2009 B2
7481810 Dumbauld et al. Jan 2009 B2
7487780 Hooven Feb 2009 B2
7491201 Shields et al. Feb 2009 B2
7491202 Odom et al. Feb 2009 B2
7500975 Cunningham et al. Mar 2009 B2
7510556 Nguyen et al. Mar 2009 B2
7513898 Johnson et al. Apr 2009 B2
7540872 Schechter et al. Jun 2009 B2
7549995 Schultz Jun 2009 B2
7553312 Tetzlaff et al. Jun 2009 B2
9095347 Shields et al. Aug 2015 B2
20010032002 McClurken Oct 2001 A1
20020013583 Camran et al. Jan 2002 A1
20020042616 Chan Apr 2002 A1
20020049442 Roberts et al. Apr 2002 A1
20020099372 Schulze et al. Jul 2002 A1
20020107517 Witt et al. Aug 2002 A1
20020111624 Witt et al. Aug 2002 A1
20020188294 Couture et al. Dec 2002 A1
20030014052 Buysse et al. Jan 2003 A1
20030014053 Nguyen et al. Jan 2003 A1
20030018331 Dycus et al. Jan 2003 A1
20030018332 Schmaltz et al. Jan 2003 A1
20030032956 Lands et al. Feb 2003 A1
20030069570 Witzel et al. Apr 2003 A1
20030069571 Treat et al. Apr 2003 A1
20030078578 Truckai et al. Apr 2003 A1
20030109875 Tetzlaff et al. Jun 2003 A1
20030109876 Yamauchi Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030139741 Goble et al. Jul 2003 A1
20030139742 Wampler et al. Jul 2003 A1
20030158548 Phan et al. Aug 2003 A1
20030158549 Swanson Aug 2003 A1
20030171747 Kanehira et al. Sep 2003 A1
20030181910 Dycus et al. Sep 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030220637 Truckai et al. Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20030236325 Bonora Dec 2003 A1
20030236518 Marchitto et al. Dec 2003 A1
20040030330 Brassell et al. Feb 2004 A1
20040030332 Knowlton et al. Feb 2004 A1
20040049185 Latterell et al. Mar 2004 A1
20040064151 Mollenauer Apr 2004 A1
20040073238 Makower Apr 2004 A1
20040073256 Marchitto et al. Apr 2004 A1
20040078035 Kanehira et al. Apr 2004 A1
20040082952 Dycus et al. Apr 2004 A1
20040087943 Dycus et al. May 2004 A1
20040115296 Duffin Jun 2004 A1
20040116924 Dycus et al. Jun 2004 A1
20040116979 Truckai et al. Jun 2004 A1
20040143263 Schechter et al. Jul 2004 A1
20040148035 Barrett et al. Jul 2004 A1
20040162557 Tetzlaff et al. Aug 2004 A1
20040193153 Sartor et al. Sep 2004 A1
20040199181 Knodel et al. Oct 2004 A1
20040210282 Flock et al. Oct 2004 A1
20040224590 Rawa et al. Nov 2004 A1
20040230189 Keppel Nov 2004 A1
20040236326 Schulze et al. Nov 2004 A1
20040243125 Dycus et al. Dec 2004 A1
20040249374 Tetzlaff et al. Dec 2004 A1
20040260281 Baxter et al. Dec 2004 A1
20050004564 Wham et al. Jan 2005 A1
20050004569 Witt et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050059934 Wenchell et al. Mar 2005 A1
20050096645 Wellman et al. May 2005 A1
20050101951 Wham et al. May 2005 A1
20050101952 Lands et al. May 2005 A1
20050113818 Sartor et al. May 2005 A1
20050113819 Wham et al. May 2005 A1
20050113826 Johnson et al. May 2005 A1
20050149017 Dycus Jul 2005 A1
20050149151 Orszulak et al. Jul 2005 A1
20050154387 Moses et al. Jul 2005 A1
20050187547 Sugi Aug 2005 A1
20050197659 Bahney Sep 2005 A1
20050203504 Wham et al. Sep 2005 A1
20060052778 Chapman et al. Mar 2006 A1
20060052779 Hammill Mar 2006 A1
20060064085 Schechter et al. Mar 2006 A1
20060064086 Odom Mar 2006 A1
20060074417 Cunningham et al. Apr 2006 A1
20060079888 Mulier et al. Apr 2006 A1
20060079890 Guerra Apr 2006 A1
20060079891 Arts et al. Apr 2006 A1
20060079933 Hushka et al. Apr 2006 A1
20060084973 Hushka Apr 2006 A1
20060089670 Hushka Apr 2006 A1
20060116675 McClurken et al. Jun 2006 A1
20060129146 Dycus et al. Jun 2006 A1
20060167450 Johnson et al. Jul 2006 A1
20060167452 Moses et al. Jul 2006 A1
20060173452 Buysse et al. Aug 2006 A1
20060189981 Dycus et al. Aug 2006 A1
20060190035 Hushka et al. Aug 2006 A1
20060217709 Couture et al. Sep 2006 A1
20060229666 Suzuki et al. Oct 2006 A1
20060253126 Bjerken et al. Nov 2006 A1
20060259036 Tetzlaff et al. Nov 2006 A1
20060264922 Sartor et al. Nov 2006 A1
20060264931 Chapman et al. Nov 2006 A1
20060283093 Petrovic et al. Dec 2006 A1
20060287641 Perlin Dec 2006 A1
20070016182 Lipson et al. Jan 2007 A1
20070016187 Weinberg et al. Jan 2007 A1
20070043352 Garrison et al. Feb 2007 A1
20070043353 Dycus et al. Feb 2007 A1
20070060919 Isaacson et al. Mar 2007 A1
20070062017 Dycus et al. Mar 2007 A1
20070074807 Guerra Apr 2007 A1
20070078456 Dumbauld et al. Apr 2007 A1
20070078458 Dumbauld et al. Apr 2007 A1
20070078459 Johnson et al. Apr 2007 A1
20070088356 Moses et al. Apr 2007 A1
20070106295 Garrison et al. May 2007 A1
20070106297 Dumbauld et al. May 2007 A1
20070118111 Weinberg May 2007 A1
20070118115 Artale et al. May 2007 A1
20070142833 Dycus et al. Jun 2007 A1
20070142834 Dumbauld Jun 2007 A1
20070156139 Schechter et al. Jul 2007 A1
20070156140 Baily Jul 2007 A1
20070173811 Couture et al. Jul 2007 A1
20070173814 Hixson et al. Jul 2007 A1
20070179499 Garrison Aug 2007 A1
20070198011 Sugita Aug 2007 A1
20070213712 Buysse et al. Sep 2007 A1
20070255279 Buysse et al. Nov 2007 A1
20070260235 Podhajsky Nov 2007 A1
20070260238 Guerra Nov 2007 A1
20070260241 Dalla Betta et al. Nov 2007 A1
20070260242 Dycus et al. Nov 2007 A1
20070265616 Couture et al. Nov 2007 A1
20080004616 Patrick Jan 2008 A1
20080009860 Odom Jan 2008 A1
20080015575 Odom et al. Jan 2008 A1
20080021450 Couture Jan 2008 A1
20080033428 Artale et al. Feb 2008 A1
20080039835 Johnson et al. Feb 2008 A1
20080039836 Odom et al. Feb 2008 A1
20080045947 Johnson et al. Feb 2008 A1
20080058802 Couture et al. Mar 2008 A1
20080082100 Orton et al. Apr 2008 A1
20080091189 Carlton Apr 2008 A1
20080114356 Johnson et al. May 2008 A1
20080167651 Tetzlaff et al. Jul 2008 A1
20080195093 Couture et al. Aug 2008 A1
20080215051 Buysse et al. Sep 2008 A1
20080243120 Lawes et al. Oct 2008 A1
20080249527 Couture Oct 2008 A1
20080312653 Arts et al. Dec 2008 A1
20080319442 Unger et al. Dec 2008 A1
20090012520 Hixson et al. Jan 2009 A1
20090018535 Schechter et al. Jan 2009 A1
20090024126 Artale et al. Jan 2009 A1
20090043304 Tetzlaff et al. Feb 2009 A1
20090048596 Shields et al. Feb 2009 A1
20090062794 Buysse et al. Mar 2009 A1
20090082766 Unger et al. Mar 2009 A1
20090082767 Unger et al. Mar 2009 A1
20090082769 Unger et al. Mar 2009 A1
20090088738 Guerra et al. Apr 2009 A1
20090088739 Hushka et al. Apr 2009 A1
20090088740 Guerra et al. Apr 2009 A1
20090088741 Hushka et al. Apr 2009 A1
20090088744 Townsend Apr 2009 A1
20090088745 Hushka et al. Apr 2009 A1
20090088746 Hushka et al. Apr 2009 A1
20090088747 Hushka et al. Apr 2009 A1
20090088748 Guerra et al. Apr 2009 A1
20090088749 Hushka et al. Apr 2009 A1
20090088750 Hushka et al. Apr 2009 A1
20090112206 Dumbauld et al. Apr 2009 A1
20090131934 Odom et al. May 2009 A1
20090149853 Shields et al. Jun 2009 A1
20090149854 Cunningham et al. Jun 2009 A1
20090171350 Dycus et al. Jul 2009 A1
20090171353 Johnson et al. Jul 2009 A1
20090182327 Unger Jul 2009 A1
20090187188 Guerra et al. Jul 2009 A1
Foreign Referenced Citations (154)
Number Date Country
2104423 Feb 1994 CA
2415263 Oct 1975 DE
02514501 Oct 1976 DE
2627679 Jan 1977 DE
03612646 Apr 1987 DE
8712328 Feb 1988 DE
04303882 Feb 1995 DE
04403252 Aug 1995 DE
19515914 Jul 1996 DE
29616210 Nov 1996 DE
19608716 Apr 1997 DE
19751106 May 1998 DE
19751108 May 1999 DE
19738457 Jan 2009 DE
0467501 Jan 1992 EP
0541930 May 1993 EP
0572131 Dec 1993 EP
0584787 Mar 1994 EP
0589555 Mar 1994 EP
0589453 Apr 1994 EP
0624348 Jun 1995 EP
0364216 Jan 1996 EP
0518230 May 1996 EP
0517243 Sep 1997 EP
0878169 Nov 1998 EP
0623316 Mar 1999 EP
0650701 Mar 1999 EP
0923907 Jun 1999 EP
0986990 Mar 2000 EP
1034747 Sep 2000 EP
1034748 Sep 2000 EP
0694290 Nov 2000 EP
1050278 Nov 2000 EP
1053719 Nov 2000 EP
1053720 Nov 2000 EP
1055399 Nov 2000 EP
1055400 Nov 2000 EP
1080694 Mar 2001 EP
1082944 Mar 2001 EP
1177771 Feb 2002 EP
1159926 Mar 2003 EP
0717966 Apr 2003 EP
1301135 Apr 2003 EP
0887046 Jul 2003 EP
1330991 Jul 2003 EP
1486177 Jun 2004 EP
1472984 Nov 2004 EP
0754437 Dec 2004 EP
1025807 Dec 2004 EP
0774232 Jan 2005 EP
0853922 Feb 2005 EP
1527747 May 2005 EP
1530952 May 2005 EP
1532932 May 2005 EP
1535581 Jun 2005 EP
1609430 Dec 2005 EP
1034746 Mar 2006 EP
1632192 Mar 2006 EP
1642543 Apr 2006 EP
1645238 Apr 2006 EP
1645240 Apr 2006 EP
1649821 Apr 2006 EP
0875209 May 2006 EP
1707143 Oct 2006 EP
1769765 Apr 2007 EP
1769766 Apr 2007 EP
1929970 Jun 2008 EP
1683496 Dec 2008 EP
623316 May 1949 GB
1490585 Nov 1977 GB
2213416 Aug 1989 GB
2214430 Sep 1989 GB
61-501068 Sep 1984 JP
65502328 Mar 1992 JP
5-5106 Jan 1993 JP
05-40112 Feb 1993 JP
06343644 Dec 1994 JP
07265328 Oct 1995 JP
08056955 Mar 1996 JP
08252263 Oct 1996 JP
09010223 Jan 1997 JP
11244298 Sep 1999 JP
2000342599 Dec 2000 JP
2000350732 Dec 2000 JP
2001008944 Jan 2001 JP
2001029356 Feb 2001 JP
2001128990 May 2001 JP
401367 Nov 1974 SU
8900757 Jan 1989 WO
9204873 Apr 1992 WO
9206642 Apr 1992 WO
9321845 Nov 1993 WO
9408524 Apr 1994 WO
9420025 Sep 1994 WO
9502369 Jan 1995 WO
9507662 Mar 1995 WO
9515124 Jun 1995 WO
9605776 Feb 1996 WO
96-22056 Jul 1996 WO
9613218 Sep 1996 WO
9700646 Jan 1997 WO
9700647 Jan 1997 WO
9710764 Mar 1997 WO
9724073 Jul 1997 WO
9724993 Jul 1997 WO
9827880 Jul 1998 WO
9903407 Jan 1999 WO
9903408 Jan 1999 WO
9903409 Jan 1999 WO
9912488 Mar 1999 WO
99-23933 May 1999 WO
9940857 Aug 1999 WO
9940861 Aug 1999 WO
9951158 Oct 1999 WO
9966850 Dec 1999 WO
0024330 May 2000 WO
0024331 May 2000 WO
0036986 Jun 2000 WO
0041638 Jul 2000 WO
0047124 Aug 2000 WO
0053112 Sep 2000 WO
0117448 Mar 2001 WO
0154604 Aug 2001 WO
0207627 Jan 2002 WO
02067798 Sep 2002 WO
02080783 Oct 2002 WO
02080784 Oct 2002 WO
02080785 Oct 2002 WO
02080786 Oct 2002 WO
02080793 Oct 2002 WO
02080794 Oct 2002 WO
02080795 Oct 2002 WO
02080796 Oct 2002 WO
02080797 Oct 2002 WO
02080798 Oct 2002 WO
02080799 Oct 2002 WO
02081170 Oct 2002 WO
03061500 Jul 2003 WO
03101311 Dec 2003 WO
03090630 Apr 2004 WO
2004032776 Apr 2004 WO
2004032777 Apr 2004 WO
2004052221 Jun 2004 WO
2004073488 Sep 2004 WO
2004073490 Sep 2004 WO
2004073753 Sep 2004 WO
2004082495 Sep 2004 WO
2004098383 Nov 2004 WO
2004103156 Dec 2004 WO
2005004734 Jan 2005 WO
2005004735 Jan 2005 WO
2005110264 Nov 2005 WO
2008045348 Apr 2008 WO
2008045350 Apr 2008 WO
Non-Patent Literature Citations (96)
Entry
Sampayan et al, “Multilayer Ultra-High Gradient Insulator Technology” Discharges and Electrical Insulation in Vacuum, 1998. Netherlands Aug. 17-21, 1998;vol. 2, pp. 740-743.
Int'l Search Report EP 98957771 dated Aug. 9, 2001.
Int'l Search Report EP 05002671.5 dated Dec. 22, 2008.
Int'l Search Report EP 05002674.9 dated Jan. 16, 2009.
Int'l Search Report EP 05019429.9 dated May 6, 2008.
Int'l Search Report EP 06008515.6 dated Jan. 8, 2009.
Int'l Search Report EP 07 014016 dated Jan. 28, 2008.
Int'l Search Report EP 07 021646.0 dated Jul. 9, 2008.
Int'l Search Report EP 07 021647.8 dated May 2, 2008.
Int'l Search Report EP 08 02692.5 dated Dec. 12, 2008.
Int'l Search Report EP 08 004655.0 dated Jun. 24, 2008.
Int'l Search Report EP 08 006732.5 dated Jul. 29, 2008.
Int'l Search Report EP 08 006917.2 dated Jul. 3, 2008.
Int'l Search Report EP 08 016539.2 dated Jan. 8, 2009.
Int'l Search Report EP 09 152267.2 dated Jun. 15, 2009.
Int'l Search Report EP 09 152898.4 dated Jun. 10, 2009.
Int'l Search Report PCT/US98/24281 dated Feb. 22, 1999.
Int'l Search Report PCT/US03/28534 dated Dec. 19, 2003.
Int'l Search Report PCT/US07/021438 dated Apr. 1, 2008.
Int'l Search Report PCT/US07/021440 dated Apr. 8, 2008.
Int'l Search Report PCT/US08/61498 dated Sep. 22, 2008.
Int'l Search Report PCT/US09/032690 dated Jun. 16, 2009.
Michael Choti, “Abdominoperineal Resection with the LigaSure Vessel Sealing System and LigaSure Atlas 20 cm Open Instrument” ; Innovations That Work, Jun. 2003.
Chung et al., “Clinical Experience of Sutureless Closed Hemorrhoidectomy with LigaSure” Diseases of the Colon & Rectum vol. 46, No. 1 Jan. 2003.
Carbonell et al., “Comparison of theGyrus PlasmaKinetic Sealer and the Valleylab LigaSure Device in the Hemostasis of Small, Medium, and Large-Sized Arteries” Carolinas Laparoscopic and Advanced Surgery Program, Carolinas Medical Center, Charlotte,NC; Date: Aug. 2003.
“Electrosurgery: A Historical Overview” Innovations in Electrosurgery; Sales/Product Literature; Dec. 31, 2000.
Johnson et al. “Evaluation of a Bipolar Electrothermal Vessel Sealing Device in Hemorrhoidectomy” Sales/Product Literature; Jan. 2004.
Muller et al., “Extended Left Hemicolectomy Using the LigaSure Vessel Sealing System” Innovations That Work, Sep. 1999.
Carus et al., “Initial Experience With the LigaSure Vessel Sealing System in Abdominal Surgery” Innovations That Work, Jun. 2002.
Heniford et al. “Initial Research and Clinical Results with an Electrothermal Bipolar Vessel Sealer” Oct. 1999.
Herman et al., “Laparoscopic Intestinal Resection With the LigaSure Vessel Sealing System: A Case Report”; Innovations That Work, Feb. 2002.
LigaSure Vessel Sealing System, the Seal of Confidence in General, Gynecologic, Urologic, and Laparaoscopic Surgery; Sales/Product Literature; Apr. 2002.
Joseph Ortenberg “LigaSure System Used in Laparoscopic 1st and 2nd Stage Orchiopexy” Innovations That Work, Nov. 2002.
Sigel et al. “The Mechanism of Blood Vessel Closure by High Frequency Electrocoagulation” Surgery Gynecology & Obstetrics, Oct. 1965 pp. 823-831.
Paul G. Horgan, “A Novel Technique for Parenchymal Division During Hepatectomy” The American Journal of Surgery, vol. 181, No. 3, Apr. 2001 pp. 236-237.
Levy et al. “Randomized Trial of Suture Versus Electrosurgical Bipolar Vessel Sealing in Vaginal Hysterectomy” Obstetrics & Gynecology, vol. 102, No. 1, Jul. 2003.
Bergdahl et al. “Studies on Coagulation and the Development of an Automatic Computerized Bipolar Coagulator” J. Neurosurg, vol. 75, Jul. 1991, pp. 148-151.
Strasberg et al. “A Phase I Study of the LigaSure Vessel Sealing System in Hepatic Surgery” Section of HPB Surger, Washington University School of Medicine, St. Louis MO, Presented at AHPBA, Feb. 2001.
Sayfan et al. “Sutureless Closed Hemorrhoidectomy: A New Technique” Annals of Surgery vol. 234 No. 1 Jul. 2001; pp. 21-24.
Levy et al., “Update on Hysterectomy—New Technologies and Techniques” OBG Management, Feb. 2003.
Dulemba et al. “Use of a Bipolar Electrothermal Vessel Sealer in Laparoscopically Assisted Vaginal Hysterectomy” Sales/Product Literature; Jan. 2004.
Strasberg et al., “Use of a Bipolar Vessel-Sealing Device for Parenchymal Transection During Liver Surgery” Journal of Gastrointestinal Surgery, vol. 6, No. 4, Jul./Aug. 2002 pp. 569-574.
Craig Johnson, “Use of the LigaSure Bessel Sealing System in Bloodless Hemorrhoidectomy” Innovations That Work, Mar. 2000.
Int'l Search Report EP 98944778 dated Oct. 31, 2000.
Int'l Search Report EP 98958575.7 dated Sep. 20, 2002.
Int'l Search Report EP 04013772 dated Apr. 1, 2005.
Int'l Search Report EP 04027314 dated Mar. 10, 2005.
Int'l Search Report EP 04027479 dated Mar. 8, 2005.
Int'l Search Report EP 04027705 dated Feb. 3, 2005.
Int'l Search Report EP 04752343.6 dated Jul. 20, 2007.
Int'l Search Report EP 05013463.4 dated Sep. 28, 2005.
Int'l Search Report EP 05013895 dated Oct. 14, 2005.
Int'l Search Report EP 05016399 dated Jan. 5, 2006.
Int'l Search Report EP 05017281 dated Nov. 16, 2005.
Int'l Search Report EP 05019130.3 dated Oct. 18, 2005.
Int'l Search Report EP 05020665.5 dated Feb. 16, 2006.
Int'l Search Report EP 05020666.3 dated Feb. 17, 2006.
Int'l Search Report EP 05021197.8 dated Jan. 31, 2006.
Int'l Search Report EP 05021779.3 dated Jan. 18, 2006.
Int'l Search Report EP 05021780.1 dated Feb. 9, 2006.
Int'l Search Report EP 05021937.7 dated Jan. 13, 2006.
Int'l Search Report—extended—EP 05021937.7 dated Mar. 6, 2006.
Int'l Search Report EP 05023017.6 dated Feb. 16, 2006.
Int'l Search Report EP 06002279.5 dated Mar. 22, 2006.
Int'l Search Report EP 06005185.1 dated Apr. 18, 2006.
Int'l Search Report EP 06006716 dated Aug. 4, 2006.
Int'l Search Report EP 06008779.8 dated Jun. 13, 2006.
Int'l Search Report EP 06014461.5 dated Oct. 20, 2006.
Int'l Search Report EP 06020574.7 dated Sep. 21, 2007.
Int'l Search Report EP 06020583.8 dated Jan. 30, 2007.
Int'l Search Report EP 06020584.6 dated Jan. 12, 2007.
Int'l Search Report EP 06020756.0 dated Feb. 5, 2007.
Int'l Search Report EP 06 024122.1 dated Mar. 19, 2007.
Int'l Search Report EP 06024123.9 dated Feb. 26, 2007.
Int'l Search Report EP 07 001480.8 dated Apr. 12, 2007.
Int'l Search Report EP 07 001488.1 dated May 29, 2007.
Int'l Search Report EP 07 009026.1 dated Sep. 12, 2007.
Int'l Search Report Extended—EP 07 009029.5 dated Jul. 12, 2007.
Int'l Search Report EP 07 009321.6 dated Aug. 17, 2007.
Int'l Search Report EP 07 010672.9 dated Oct. 1, 2007.
Int'l Search Report EP 07 013779.9 dated Oct. 18, 2007.
Int'l Search Report EP 07 015191.5 dated Dec. 19, 2007.
Int'l Search Report EP 07 015601.3 dated Dec. 6, 2007.
Int'l Search Report EP 07 020283.3 dated Jan. 16, 2008.
Int'l Search Report PCT/US98/18640 dated Dec. 17, 1998.
Int'l Search Report PCT/US98/23950 dated Dec. 29, 1998.
Int'l Search Report PCT/US99/24869 dated Feb. 3, 2000.
Int'l Search Report PCT/US01/11218 dated Aug. 3, 2001.
International Search Report PCT/US01/11224 dated Nov. 13, 2001.
Int'l Search Report PCT/US01/11340 dated Aug. 7, 2001.
Int'l Search Report PCT/US01/11420 dated Oct. 8, 2001.
Int'l Search Report PCT/US02/01890 dated Jul. 17, 2002.
Int'l Search Report PCT/US02/11100 dated Jul. 9, 2002.
Int'l Search Report PCT/US04/03436 dated Oct. 5, 2004.
Int'l Search Report PCT/US04/13273 dated Nov. 22, 2004.
Int'l Search Report PCT/US04/15311 dated Nov. 18, 2004.
Related Publications (1)
Number Date Country
20150320486 A1 Nov 2015 US
Divisions (1)
Number Date Country
Parent 10718379 Nov 2003 US
Child 12212780 US
Continuations (1)
Number Date Country
Parent 12212780 Sep 2008 US
Child 14806135 US